Improper payments have long been an avoidable drain on the federal budget and are often prominently featured as an example of wasteful spending. It is therefore not surprising that in the August 12, 2025, Government Accountability Office (GAO) updated report on open recommendations to improve government operations, reducing fraud and improper payments was first on […]
The Inflation Reduction Act creates instability in the Medicare Part D Program.
The Inflation Reduction Act will ultimately raise drug costs and reduce future cures.
Taxpayers and beneficiaries should be concerned with the Biden administration’s proposed cuts to Medicare Advantage.
IRA drug price controls will devastate future drug development, resulting in more lives lost.
House Democrats’ new bill on price controls will devastate future drug development and raise costs.
The Center for Medicare and Medicaid Innovation (CMMI) sounds like it should be involved in ground-breaking, state-of-the-art healthcare projects and programs. However, the center was created in the Patient Protection and Affordable Care Act (ACA), better known as Obamacare, which in and of itself raises red flags. CMMI is run by the Centers for Medicare […]
Citizens Against Government Waste’s February Waste Watcher, “Obamacare’s Cerberus,” discussed concerns with three organizations created under the Affordable Care Act (ACA), or Obamacare. They are the Patient Centered Outcome Research Institute (PCORI), the Independent Payment Advisory Board (IPAB), and the Center for Medicare and Medicaid Innovation (CMMI.) All have the capability to develop into government rationing boards.
In March 2010, the Affordable Care Act (ACA), or Obamacare, was signed into law. The debate over controversial Obamacare initiatives is ongoing, particularly whether the law will lead to rationing and price-controls that are seen in single-payer or government-run healthcare systems.
For many years, the Government Accountability Office and the Department of Health and Human Services (HHS) Office of the Inspector General have issued report after report pointing out that Medicare pays too much for durable medical equipment (DME). DME includes walkers, wheelchairs, and portable oxygen equipment. Unfortunately for taxpayers, Medicare’s fee schedule is not based on competitive market prices.
